1. Home/
  2. Compounds/
  3. BRD-K27188169:navitoclax (2:1 mol/mol)

BRD-K27188169:navitoclax (2:1 mol/mol)


SourcesNames Used
CTRPv2BRD-K27188169:navitoclax (2:1 mol/mol)
PharmacoGx BRD-K27188169:navitoclax (2:1 mol/mol)

Cell lines tested with BRD-K27188169:navitoclax (2:1 mol/mol)

373 cell lines have been tested with this compound, using data from 1 dataset(s).
CAS-1 central nervous system CTRPv21
KPL-1 breast CTRPv21
MKN1 stomach CTRPv21
253J-BV urinary tract CTRPv21
BFTC-905 urinary tract CTRPv21
BFTC-909 urinary tract CTRPv21
CAL-120 breast CTRPv21
CAL-29 urinary tract CTRPv21
NMC-G1 central nervous system CTRPv21
RPMI-7951 skin CTRPv21
Download CSV

Tissues tested with BRD-K27188169:navitoclax (2:1 mol/mol)

24 tissues have been tested with this compound, using data from 1 dataset(s).
central nervous systemCTRPv221
urinary tractCTRPv215
soft tissueCTRPv24
Download CSV
Download Data as CSV

Top molecular features associated with response to BRD-K27188169:navitoclax (2:1 mol/mol)

Feature TypeStandardized
Nominal ANOVA
mRNA BEND5 CTRPv2 AAC 0.39 7e-14
mRNA BCL2 CTRPv2 AAC 0.39 9e-13
mRNA DUSP26 CTRPv2 AAC 0.32 7e-10
mRNA CIC CTRPv2 AAC 0.32 9e-10
mRNA WDR7 CTRPv2 AAC 0.34 2e-09
mRNA GRIK5 CTRPv2 AAC 0.32 2e-09
mRNA PTOV1 CTRPv2 AAC 0.3 3e-09
mRNA ZNF428 CTRPv2 AAC 0.3 4e-09
mRNA HDHD2 CTRPv2 AAC 0.32 1e-08
mRNA STMN1 CTRPv2 AAC 0.29 3e-08
Download CSV